344 related articles for article (PubMed ID: 15451781)
1. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F
Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781
[TBL] [Abstract][Full Text] [Related]
2. Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo.
Struthmann L; Hellwig N; Pircher J; Sohn HY; Buerkle MA; Klauss V; Mannell H; Pohl U; Krötz F
J Thromb Haemost; 2009 Oct; 7(10):1727-35. PubMed ID: 19691487
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
Belton OA; Duffy A; Toomey S; Fitzgerald DJ
Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
[TBL] [Abstract][Full Text] [Related]
5. Progestogens stimulate prostacyclin production by human endothelial cells.
Hermenegildo C; Oviedo PJ; García-Martínez MC; García-Pérez MA; Tarín JJ; Cano A
Hum Reprod; 2005 Jun; 20(6):1554-61. PubMed ID: 15734756
[TBL] [Abstract][Full Text] [Related]
6. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
9. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation.
Borgdorff P; Tangelder GJ; Paulus WJ
J Am Coll Cardiol; 2006 Aug; 48(4):817-23. PubMed ID: 16904555
[TBL] [Abstract][Full Text] [Related]
11. Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro.
Wang MM; Xue M; Xu YG; Miao Y; Kou N; Yang L; Zhang Y; Shi DZ
Thromb Res; 2016 May; 141():146-52. PubMed ID: 27043068
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.
Dowd NP; Scully M; Adderley SR; Cunningham AJ; Fitzgerald DJ
J Clin Invest; 2001 Aug; 108(4):585-90. PubMed ID: 11518732
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis.
Tanaka N; Sato T; Fujita H; Morita I
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):607-12. PubMed ID: 14726416
[TBL] [Abstract][Full Text] [Related]
14. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
[TBL] [Abstract][Full Text] [Related]
15. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.
Giuliano F; Mitchell JA; Warner TD
J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells.
Mark KS; Trickler WJ; Miller DW
J Pharmacol Exp Ther; 2001 Jun; 297(3):1051-8. PubMed ID: 11356928
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
Schrör K
Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
[TBL] [Abstract][Full Text] [Related]
18. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
[TBL] [Abstract][Full Text] [Related]
20. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
